IL6 and COVID-19: Also, the CSF IL-6, IL-8, IL-15, and monocyte inhibitory protein (MIP)-1β levels were higher in COVID-19 patients with neurological symptoms compared to controls and human immunodeficiency virus (HIV) patients, with evidence of BBB disruption [320].